BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 24, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 26, 2018
View Archived Issues
Galapagos reports Part 1 interim results from FALCON trial of cystic fibrosis combination treatment
Read More
SCHAD role in the regulation of insulin secretion in pathogenic genetic variants and mouse models
Read More
A rare mutation in ABCC1 alters APP processing in a familial case of late-onset Alzheimer's disease
Read More
SGLT1 variants lower postprandial glucose and may protect from long-term cardiometabolic risk
Read More
USP22 controls cell cycle progression in cancer cells through CCND1 deubiquitylation
Read More
LCL-161/paclitaxel neoadjuvant trial for triple-negative breast cancers stratified by gene signature
Read More
Phase II study of the IGF-1 mimetic BVS-857 for patients with spinal and bulbar muscular atrophy
Read More
[18F]T-401, a promising PET tracer for the in vivo quantification of brain MGL occupancy
Read More
Inovio presents updated results from HVTN 098 phase I clinical study of PENNVAX-GP
Read More
First patient dosed in phase II study of CPC-634 for the treatment of ovarian cancer
Read More
Interim analysis results presented from phase IIb EMMINENCE study of MSDC-0602K
Read More
Japanese investigators patent new anti-HBV compounds
Read More
DAYBREAK phase III study of Lu-AF-35700 does not meet primary endpoint
Read More
Aerie Pharmaceuticals patents protein kinase inhibitors
Read More
U.S. researchers divulge new SCN9A blockers
Read More
Sidecar Therapeutics identifies LOXL2 and MAP3K5 inhibitors
Read More
Syndax provides updates on two entinostat trials
Read More
SpinalCyte presents 12-month data from phase I/II study of CybroCell in degenerative disc disease
Read More
Treatment initiates in first-in-human PIONEER study of GS-030
Read More
Alnylam expands Alnylam Act program and provides update on lumasiran studies
Read More
Better than Juuling: "Biochemical cigarette" resets metabolism
Read More
Fujian Guangshengtang Pharmaceutical cleared to begin clinical trials of GST-HG-161 in China
Read More
First patient dosed in MAVA long-term extension study of mavacamten
Read More
Ultragenyx to discontinue its Glut1 DS development program
Read More
